Evaluating the effectiveness of different intensities of behavioral interventions for childhood obesity
Official title: The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity
Run by Vanderbilt University Medical Center · NCT06654323 · Data updated 2026-11-12
This study is testing how different amounts of support for healthy habits can help children aged 5-17 with obesity feel better and improve their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 17 Years |
| Sex | All |
| Enrollment | 900 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 2 sites (Baton Rouge, Louisiana and 1 other locations) |
| Status | Recruiting |
| Started | February 20, 2025 |
| Main results expected | August 1, 2028 |
| Study ends | August 1, 2028 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT06654323 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 5-17 with obesity, defined as having a BMI at or above the 95th percentile for their age and sex.
✕Probably not a fit
Patients with developmental delays, disordered eating, mobility impairments, or other medical conditions deemed inappropriate for the intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine the optimal number of hours for intensive behavioral lifestyle interventions in treating childhood obesity among children aged 5-17. A total of 900 children will be randomly assigned to receive varying doses of intervention, ranging from 13 to 26 hours, over a six-month period. The study will assess changes in body mass index (BMI), diet, exercise, sleep, media use, and quality of life before and after the intervention. The research focuses on rural and minority populations in Tennessee and Louisiana, integrating the intervention into local pediatric primary care practices.
Why it matters
Potential benefit: If successful, this study could provide insights into effective, resource-efficient interventions for childhood obesity, potentially improving health outcomes for children.
How similar studies have gone: Previous studies have shown varying success with behavioral interventions for childhood obesity, but this specific approach of testing different intervention intensities is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI≥95th percentile for age and sex based on standardized CDC growth curves. * parent/caregiver aged ≥ 18 years old * are comfortable speaking and reading English or Spanish; * are a patient of a participating clinical practice; * are able to provide written or verbal consent/assent; * are able to attend scheduled sessions in the 12-month study; * are willing to make behavioral and lifestyle changes; * are able to access the internet to participate in online intervention components; * complete baseline data collection, including child height and weight; and * complete at least 90% of baseline survey items no later than 14 days after the baseline visit. Exclusion Criteria: * families for whom the primary care provider (PCP) or site principal investigator (PI) thinks the study and/or intervention is clinically/medically inappropriate (e.g. developmental delay, disordered eating, mobility impairments, cognitive or mental difficulties); * participant child is taking weight management medications at the time of enrollment; * participant child plans to undergo bariatric surgery or another weight loss operation during the 12-month study; or * participant caregiver-child dyad has plans to move during the 12-month study and will no longer be a patient of a participating clinic.
Where it's running
-
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: William Heerman, MD MPH — Vanderbilt University Medical Center
- Study coordinator: Filoteia Popescu
- Email: filoteia.popescu@vumc.org
- Phone: 615-322-7080
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Progressive Neuromuscular Stabilization vs. Aerobic Exercise for Obesity in Children
This study tests whether technology-assisted progressive neuromuscular stabilization exercises can improve body composition and balance in children with obesity, compared with standard aerobic exercise.
-
MRI study to see how obesity treatments affect body and organ fat in severely obese kids
This study tests whether adding a GLP-1 receptor agonist to lifestyle changes helps improve body composition and organ fat in adolescents with severe obesity.
-
Bottle flow-rate test for babies and feeding patterns
This study tests whether different bottle nipple flow rates affect how much milk a 4–6 month old infant drinks, how they feed, and their sleep, by watching 220 mother–infant pairs.
-
Mountain West Family Healthy Weight Program
This project will test whether text message outreach and direct enrollment in a community healthy‑weight program help lower‑income families with a 5–12 year old child with obesity sign up for and stay engaged in the program.
-
Exercise after pregnancy to activate infant brown fat
This study will test if a mother's exercise during pregnancy and after birth changes her breast milk so it increases her infant's brown fat activity and energy use.
-
Phentermine to help teens with obesity
This Phase IIb trial will test whether 16 mg of phentermine daily can help overweight adolescents aged 12 to under 18 compared with placebo over a year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.